CLINICAL_TRIALS
trial_result
· 2018-12-06
Clinical Trial Update: Study of A-101 for the Treatment of Seborrheic Keratosis [Phase 2]
Summary
Phase 2 clinical trial studying A-101 for seborrheic keratosis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Aclaris Therapeutics, Inc. | Conditions: Seborrheic Keratosis | Phase 2 | Status: COMPLETED | Results posted: 2018-12-06